Register for free to listen to this article
Listen with Speechify
0:00
1:00
<!-- /* Font Definitions */@font-face {font-family:"Times New Roman"; panose-1:0 2 2 6 3 5 4 5 2 3; mso-font-charset:0; mso-generic-font-family:auto; mso-font-pitch:variable; mso-font-signature:50331648 0 0 0 1 0;} /* Style Definitions */p.MsoNormal, li.MsoNormal, div.MsoNormal {mso-style-parent:""; margin:0in; margin-bottom:.0001pt; mso-pagination:widow-orphan; font-size:12.0pt; font-family:"Times New Roman";}@page Section1 {size:8.5in 11.0in; margin:1.0in 1.25in 1.0in 1.25in; mso-header-margin:.5in; mso-footer-margin:.5in; mso-paper-source:0;}div.Section1 {page:Section1;}-->
Micronic Europe BV
 
 
The ScrewCap DeCapper available from Micronic Europe BV is acompact, automated instrument for the opening and closing of screw-capped tubes(0.5 - 1.4ml). The programmable ScrewCap DeCapper opens a row of 12 tubessimultaneously, increasing productivity over one-at-a-time methods andproviding more flexibility than systems that decap 96 tubes at once. Decappingor recapping of a complete rack of 96-screw capped tubes takes less than oneminute. The instrument operates from outside to inside rows, eliminating thepossibility of drip contamination that can occur with the 96-tube decappers.Built-in torque monitoring ensures a consistent seal and reports the exactlocation in the event a tube is not completely sealed. After removal, the capsare placed on a separate, removable cap holder, which enables batch processing.The ScrewCap DeCapper can operate as a standalone system or can be simplyintegrated with most commercial automated pipetting workstations.

Micronic Europe BV

+31-320-277070

www.micronic.com 

Related Topics

Published In

Loading Next Article...
Loading Next Article...
Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

Gold circles with attached purple corkscrew shapes represent gold nanoparticles against a black background.

Driving gene therapy with nonviral vectors 

Learn why nonviral vectors are on the rise in gene therapy development.
A 3D digital illustration of a viral spike protein on a cell surface, surrounded by colorful, floating antibodies in the background

Milestone: Leapfrogging to quantitative, high throughput protein detection and analysis

Researchers continuously push the boundaries of what’s possible with protein analysis tools.
Blue cancer cells attached to a cellular surface against a bright blue background in a 3D rendering of a cancer infection.

Advancing immuno-oncology research with cellular assays

Explore critical insights into immunogenicity and immunotoxicity assays for cancer therapies.
Drug Discovery News November 2024 Issue
Latest IssueVolume 20 • Issue 6 • November 2024

November 2024

November 2024 Issue

Explore this issue